Humana Inc. $HUM Shares Bought by Allworth Financial LP

Allworth Financial LP lifted its position in shares of Humana Inc. (NYSE:HUM) by 187.6% in the second quarter, according to its most recent 13F filing with the SEC. The firm owned 1,599 shares of the insurance provider’s stock after purchasing an additional 1,043 shares during the quarter. Allworth Financial LP’s holdings in Humana were worth $391,000 as of its most recent filing with the SEC.

Several other hedge funds have also recently bought and sold shares of the business. Vanguard Group Inc. raised its holdings in Humana by 8.9% in the first quarter. Vanguard Group Inc. now owns 13,972,872 shares of the insurance provider’s stock valued at $3,697,222,000 after acquiring an additional 1,143,662 shares in the last quarter. Dodge & Cox raised its stake in shares of Humana by 5.5% in the 1st quarter. Dodge & Cox now owns 10,755,215 shares of the insurance provider’s stock valued at $2,845,830,000 after purchasing an additional 557,175 shares in the last quarter. Pzena Investment Management LLC lifted its position in shares of Humana by 6.5% during the second quarter. Pzena Investment Management LLC now owns 4,076,667 shares of the insurance provider’s stock worth $996,664,000 after purchasing an additional 247,744 shares during the last quarter. Davis Selected Advisers grew its stake in Humana by 3.3% in the first quarter. Davis Selected Advisers now owns 2,331,343 shares of the insurance provider’s stock worth $616,873,000 after purchasing an additional 74,434 shares in the last quarter. Finally, Hotchkis & Wiley Capital Management LLC grew its stake in Humana by 1.6% in the first quarter. Hotchkis & Wiley Capital Management LLC now owns 1,236,936 shares of the insurance provider’s stock worth $327,293,000 after purchasing an additional 19,613 shares in the last quarter. Hedge funds and other institutional investors own 92.38% of the company’s stock.

Analysts Set New Price Targets

A number of equities research analysts have recently weighed in on the company. Robert W. Baird lowered their price target on Humana from $300.00 to $297.00 and set a “neutral” rating for the company in a report on Friday, July 25th. Wells Fargo & Company boosted their target price on shares of Humana from $344.00 to $347.00 and gave the company an “overweight” rating in a research note on Tuesday, October 7th. Evercore ISI started coverage on shares of Humana in a report on Monday, September 22nd. They set an “in-line” rating and a $295.00 target price on the stock. Piper Sandler decreased their price target on shares of Humana from $288.00 to $272.00 and set a “neutral” rating for the company in a report on Thursday, July 31st. Finally, Barclays lowered their price objective on shares of Humana from $315.00 to $245.00 and set an “equal weight” rating for the company in a research report on Friday, October 3rd. Eight research analysts have rated the stock with a Buy rating, nine have assigned a Hold rating and two have issued a Sell rating to the company. According to data from MarketBeat, the stock has an average rating of “Hold” and a consensus target price of $298.39.

Humana Stock Performance

HUM opened at $236.94 on Monday. The business has a 50 day moving average price of $271.04 and a two-hundred day moving average price of $258.01. The company has a debt-to-equity ratio of 0.69, a current ratio of 1.95 and a quick ratio of 1.95. The company has a market capitalization of $28.50 billion, a price-to-earnings ratio of 18.18, a price-to-earnings-growth ratio of 1.71 and a beta of 0.42. Humana Inc. has a 1-year low of $206.87 and a 1-year high of $315.35.

Humana (NYSE:HUM) last posted its quarterly earnings data on Wednesday, November 5th. The insurance provider reported $3.24 EPS for the quarter, topping analysts’ consensus estimates of $2.95 by $0.29. Humana had a return on equity of 13.67% and a net margin of 1.28%.The company had revenue of $32.65 billion for the quarter, compared to the consensus estimate of $31.99 billion. During the same quarter in the previous year, the business earned $4.16 EPS. The company’s quarterly revenue was up 11.1% compared to the same quarter last year. Research analysts predict that Humana Inc. will post 16.47 EPS for the current fiscal year.

Humana Announces Dividend

The firm also recently announced a quarterly dividend, which will be paid on Friday, January 30th. Investors of record on Friday, December 26th will be issued a $0.885 dividend. This represents a $3.54 dividend on an annualized basis and a dividend yield of 1.5%. The ex-dividend date is Friday, December 26th. Humana’s payout ratio is presently 33.18%.

About Humana

Humana Inc, together with its subsidiaries, provides medical and specialty insurance products in the United States. It operates through two segments, Insurance and CenterWell. The company offers medical and supplemental benefit plans to individuals. It has a contract with Centers for Medicare and Medicaid Services to administer the Limited Income Newly Eligible Transition prescription drug plan program; and contracts with various states to provide Medicaid, dual eligible, and long-term support services benefits.